On July 5, 2004, Pfizer's China group got frustrating news. China's patent evaluation board simply revoked the business's existing patent on among its most effective drugs, Viagra. Making matters worse, a Guangdong-based pharmaceutical business claimed Viagra's street name "Wei Ge" (Great Brother), saying that the term was not a widely known hallmark in China.
With 2 suits relevant to copyright rights now pending in China, Pfizer questioned whether trade politics or the guideline of law would dominate.
Real Blue Viagra and Intellectual Property Rights Law in China Case Study Solution
PUBLICATION DATE: February 17, 2010 PRODUCT #: 910409-PDF-ENG
This is just an excerpt. This case is about GLOBAL BUSINESS
Related Case Solutions & Analyses:
Low-Carbon, Indigenous Innovation in China
A New Approach to Fix Broken Governance
Pepsi-BASIX Partnership
A350 XWB: Airbus’ answer to Boeing’s Dreamliner
Everything or Nothing: Martti Ahtisaari and the Aceh Negotiations (A)
John Maynard Keynes: His Life, Times, and Writings
Corning, Inc.: A Network of Alliances, Spanish Version
Fonterra: Taking on the Dairy World
China’s Rural Leap Forward
The Business of Peace: Coca-Cola’s Contribution to Stability, Growth, and Optimism
